Anhedonia predicts poor psychosocial functioning: Results from a large cohort of patients treated for major depressive disorder by general practitioners

European Psychiatry

Volumn 44, Issue , 2017, Pages 1-8

  Vinckier, F ^a,b   Gourion, D ^c   Mouchabac, S ^d  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c université Paris 6 ^*  (France)

^d HÔPITAL SAINT ANTOINE   (France)

Author keywords

Agomelatine; Anhedonia; Antidepressant; Psychosocial functioning; Quality of life; Unipolar depression

Indexed keywords

AGOMELATINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ANTIDEPRESSANT AGENT;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANHEDONIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL FEATURE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL PRACTICE; COHORT ANALYSIS; DEPRESSION ASSESSMENT; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL LEAVE; MIDDLE AGED; MONOTHERAPY; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; REMISSION; RETURN TO WORK; SNAITH HAMILTON PLEASURE SCALE; SOCIAL INTERACTION; SOCIAL PSYCHOLOGY; SUICIDE ATTEMPT; TREATMENT RESPONSE; UNEMPLOYMENT; COPING BEHAVIOR; OUTPATIENT; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SOCIAL ADAPTATION; TREATMENT OUTCOME;

ADAPTATION, PSYCHOLOGICAL; ADULT; ANHEDONIA; ANTIDEPRESSIVE AGENTS; COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENERAL PRACTITIONERS; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; SEVERITY OF ILLNESS INDEX; SOCIAL ADJUSTMENT; TREATMENT OUTCOME;

EID: 85019861592     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2017.02.485     Document Type: Article

References (42)

1. Der-Avakian, A., Markou, A., The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci 35:1 (2012), 68–77.
2. Rizvi, S.J., Pizzagalli, D.A., Sproule, B.A., Kennedy, S.H., Assessing anhedonia in depression: potentials and pitfalls. Neurosc Biobehav Rev 65 (2016), 21–35.
3. Spijker, J., Bijl, R.V., de Graaf, R., Nolen, W.A., Determinants of poor 1-year outcome of DSM-III-R major depression in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Acta Psychiatr Scand 103:2 (2001), 122–130.
4. Uher, R., Perlis, R., Henigsberg, N., Zobel, A., Rietschel, M., Mors, O., et al. Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms. Psychol Med 42:05 (2012), 967–980.
5. McMakin, D.L., Olino, T.M., Porta, G., Dietz, L.J., Emslie, G., Clarke, G., et al. Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression. J Am Acad Child Adolesc Psychiatry 51:4 (2012), 404–411.
6. Lam, R.W., Filteau, M.J., Milev, R., Clinical effectiveness: the importance of psychosocial functioning outcomes. J Affect Disord 132:Suppl. 1 (2011), S9–S13.
7. Kennedy, N., Foy, K., Sherazi, R., McDonough, M., McKeon, P., Long-term social functioning after depression treated by psychiatrists: a review. Bipolar Disord 9:1-2 (2007), 25–37.
8. Bosc, M., Assessment of social functioning in depression. Compr Psychiatry 41:1 (2000), 63–69.
9. Hirschfeld, R., Montgomery, S.A., Keller, M.B., Kasper, S., Schatzberg, A.F., Möller, H.-J., et al. Social functioning in depression: a review. J Clin Psychiatry, 2000.
10. Miller, I.W., Keitner, G.I., Schatzberg, A.F., Klein, D.N., Thase, M.E., Rush, A.J., et al. The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry, 1998.
11. Solomon, D.A., Leon, A.C., Endicott, J., Mueller, T.I., Coryell, W., Shea, M.T., et al. Psychosocial impairment and recurrence of major depression. Compr Psychiatry 45:6 (2004), 423–430.
12. Weissman, M.M., Social functioning and the treatment of depression. J Clin Psychiatry, 2000.
13. Zimmerman, M., McGlinchey, J.B., Posternak, M.A., Friedman, M., Boerescu, D., Attiullah, N., Discordance between self-reported symptom severity and psychosocial functioning ratings in depressed outpatients: implications for how remission from depression should be defined. Psychiatry Res 141:2 (2006), 185–191.
14. Zimmerman, M., McGlinchey, J.B., Posternak, M.A., Friedman, M., Boerescu, D., Attiullah, N., Remission in depressed outpatients: more than just symptom resolution?. J Psychiatr Res 42:10 (2008), 797–801.
15. Buckner, J.D., Joiner, T.E. Jr., Pettit, J.W., Lewinsohn, P.M., Schmidt, N.B., Implications of the DSM's emphasis on sadness and anhedonia in major depressive disorder. Psychiatry Res 159:1–2 (2008), 25–30.
16. Snaith, R.P., Hamilton, M., Morley, S., Humayan, A., Hargreaves, D., Trigwell, P., A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. BJP 167:1 (1995), 99–103.
17. Loas, G., Dubal, S., Perot, P., Tirel, F., Nowaczkowski, P., Pierson, A., Étude de validation de la version française de l’échelle de plaisir de Snaith et Hamilton (Snaith-Hamilton Pleasure Scale, SHAPS, Snaith et al., 1995): détermination des paramètres métrologiques chez 208 sujets sains et chez 103 malades hospitalisés présentant une dépression ou une schizophrénie. Encephale 23:6 (1997), 454–458.
18. Zanello, A., Weber Rouget, B., Gex-Fabry, M., Maercker, A., Guimon, J., Validation du Questionnaire de fonctionnement social (QFS), un autoquestionnaire mesurant la fréquence et la satisfaction des comportements sociaux d'une population adulte psychiatrique. Encephale 32:1 (2006), 45–59.
19. Nicastro, R., Zanello, A., Merlo, M., McQuillan, A., Caractéristiques psychométriques du questionnaire de fonctionnement social chez des patients borderline. Encephale 35:5 (2009), 436–442.
20. Martinotti, G., Sepede, G., Gambi, F., Di Iorio, G., De Berardis, D., Di Nicola, M., et al. Agomelatine versus venlafaxine XR in the treatment of anhedonia in major depressive disorder: a pilot study. J Clin Psychopharmacol 32:4 (2012), 487–491.
21. Di Giannantonio, M., Martinotti, G., Anhedonia and major depression: the role of agomelatine. Eur Neuropsychopharmacol 22:Suppl. 3 (2012), S505–S510.
22. Di Giannantonio, M., Di Iorio, G., Guglielmo, R., De Berardis, D., Conti, C., Acciavatti, T., et al. Major depressive disorder, anhedonia and agomelatine: an open-label study. J Biol Regul Homeost Agents 25:1 (2010), 109–114.
23. Montgomery, S.A., Asberg, M., A new depression scale designed to be sensitive to change. BJP 134:4 (1979), 382–389.
24. Busner, J., Targum, S.D., The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont), 4(7), 2007, 28.
25. Nakonezny, P.A., Carmody, T.J., Morris, D.W., Kurian, B.T., Trivedi, M.H., Psychometric evaluation of the Snaith-Hamilton pleasure scale in adult outpatients with major depressive disorder. Int Clin Psychopharmacol 25:6 (2010), 328–333.
26. Franken, I.H., Rassin, E., Muris, P., The assessment of anhedonia in clinical and non-clinical populations: further validation of the Snaith-Hamilton Pleasure Scale (SHAPS). J Affect Disord 99:1–3 (2007), 83–89.
27. Keller, M.B., Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond. JAMA 289:23 (2003), 3152–3160.
28. Trivedi, M.H., Corey-Lisle, P.K., Guo, Z., Lennox, R.D., Pikalov, A., Kim, E., Remission, response without remission, and nonresponse in major depressive disorder: impact on functioning. Int Clin Psychopharmacol 24:3 (2009), 133–138.
29. Romera, I., Perez, V., Menchon, J.M., Delgado-Cohen, H., Polavieja, P., Gilaberte, I., Social and occupational functioning impairment in patients in partial versus complete remission of a major depressive disorder episode. A six-month prospective epidemiological study. Eur Psychiatry 25:1 (2010), 58–65.
30. Romera, I., Perez, V., Menchon, J.M., Polavieja, P., Gilaberte, I., Optimal cutoff point of the Hamilton Rating Scale for Depression according to normal levels of social and occupational functioning. Psychiatry Res 186:1 (2011), 133–137.
31. Kennedy, N., Paykel, E., Residual symptoms at remission from depression: impact on long-term outcome. J Affect Disord 80:2 (2004), 135–144.
32. Judd, L.L., Akiskal, H.S., Zeller, P.J., Paulus, M., Leon, A.C., Maser, J.D., et al. Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psychiatry 57:4 (2000), 375–380.
33. Zimmerman, M., Posternak, M.A., Chelminski, I., Heterogeneity among depressed outpatients considered to be in remission. Compr Psychiatry 48:2 (2007), 113–117.
34. Zimmerman, M., Martinez, J., Attiullah, N., Friedman, M., Toba, C., Boerescu, D.A., et al. Further evidence that the cutoff to define remission on the 17-item Hamilton Depression Rating Scale should be lowered. Depress Anxiety 29:2 (2012), 159–165.
35. Zimmerman, M., Posternak, M.A., Chelminski, I., Is the cutoff to define remission on the Hamilton Rating Scale for Depression too high?. J Nerv Ment Dis 193:3 (2005), 170–175.
36. Romera, I., Pérez, V., Caballero, L., Roca, M., Polavieja, P., Gilaberte, I., Residual symptoms and functioning in depression, does the type of residual symptom matter? A post-hoc analysis. BMC Psychiatry, 13(1), 2013, 51.
37. Romera, I., Perez, V., Quail, D., Berggren, L., Lenox-Smith, A., Gilaberte, I., Individual residual symptoms and functional impairment in patients with depression. Psychiatry Res 220:1–2 (2014), 258–262.
38. Mintz, J., Mintz, L.I., Arruda, M.J., Hwang, S.S., Treatments of depression and the functional capacity to work. Arch Gen Psychiatry 49:10 (1992), 761–768.
39. Finkelstein, S.N., Berndt, E.R., Greenberg, P.E., Parsley, R.A., Russell, J.M., Keller, M.B., Improvement in subjective work performance after treatment of chronic depression: some preliminary results. Chronic Depression Study Group. Psychopharmacol Bull 32:1 (1995), 33–40.
40. Hirschfeld, R.M., Dunner, D.L., Keitner, G., Klein, D.N., Koran, L.M., Kornstein, S.G., et al. Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. Biol Psychiatry 51:2 (2002), 123–133.
41. Paykel, E.S., Weissman, M.M., Social adjustment and depression: a longitudinal study. Arch Gen Psychiatry 28:5 (1973), 659–663.
42. Warden, D., Rush, A.J., Trivedi, M.H., Fava, M., Wisniewski, S.R., The STAR*D Project results: a comprehensive review of findings. Curr Psychiatry Rep 9:6 (2007), 449–459.